Kirtland Hills Capital Management LLC Buys Shares of 7,697 Danaher Corporation $DHR

Key Points

• Kirtland Hills Capital Management acquired 7,697 Danaher shares in the second quarter, valued at approximately $1.47 million. Institutional investors and hedge funds collectively own 79.05% of Danaher’s stock.
• Danaher reported quarterly earnings of $1.94 per share and revenue of $6.26 billion, exceeding analyst estimates; revenue increased 5.5% year over year.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and an average price target of $228.91, although several firms recently lowered their targets.

Kirtland Hills Capital Management LLC bought a new stake in shares of Danaher Corporation (NYSE:DHR - Free Report) in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 7,697 shares of the conglomerate's stock, valued at approximately $1,466,000.

A number of other hedge funds have also made changes to their positions in DHR. Main Street Group LTD acquired a new stake in Danaher in the first quarter valued at $25,000. N.E.W. Advisory Services LLC acquired a new position in Danaher during the 2nd quarter worth $25,000. JPL Wealth Management LLC bought a new stake in shares of Danaher in the 3rd quarter worth about $25,000. WFA of San Diego LLC bought a new stake in shares of Danaher in the 2nd quarter worth about $26,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in shares of Danaher in the 4th quarter valued at about $27,000. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Stock Up 1.6%

Danaher stock opened at $219.42 on Friday. The company has a 50-day simple moving average of $195.80 and a 200-day simple moving average of $192.61. The firm has a market capitalization of $154.25 billion, a P/E ratio of 38.97, a P/E/G ratio of 2.72 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. Danaher's quarterly revenue was up 5.5% compared to the same quarter last year. During the same period last year, the firm posted $0.77 EPS. As a group, equities analysts expect that Danaher Corporation will post 8.53 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Stifel Nicolaus decreased their price target on Danaher from $260.00 to $220.00 and set a "buy" rating for the company in a research note on Wednesday, July 22nd. Wall Street Zen cut Danaher from a "buy" rating to a "hold" rating in a research note on Saturday, April 25th. HSBC decreased their target price on Danaher from $270.00 to $230.00 and set a "buy" rating for the company in a research report on Wednesday, June 3rd. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and issued a $240.00 price target on shares of Danaher in a report on Wednesday, July 22nd. Finally, Royal Bank Of Canada upped their price target on Danaher from $200.00 to $215.00 and gave the company an "outperform" rating in a research report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $228.91.

About Danaher

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source